In a bold move to protect Delhiites from counterfeit pharmaceuticals, the city’s Drugs Control Department executed a special enforcement drive in Nangloi on the directives of Health Minister Pankaj Kumar Singh. The operation targeted retail drug dealers, inspecting 12 outlets and flagging 10 for serious breaches of the 1945 Drugs Rules.
Legal actions have been set in motion under the Drugs and Cosmetics Act against these non-compliant firms. Additionally, 49 drug samples were seized for detailed quality verification through testing. This comprehensive approach aims to eliminate unfair trade practices and guarantee access to safe, high-quality medicines.
Inspectors noted illegal discount promotions on prescription drugs, with offending signage promptly dismantled and firms instructed to comply fully with regulations. Such proactive measures prevent the proliferation of substandard products that could jeopardize patient safety.
Dr. Pankaj Kumar Singh, Delhi’s Health Minister, declared a firm stance: ‘Our government is resolute in shielding the public from fake and inferior drugs. Violations will face accelerated enforcement—no exceptions.’ This pledge reflects an ongoing push to strengthen ethical standards in the pharma sector.
The department’s efforts echo prior initiatives, such as the nationwide inspection blitz on anti-cancer medications, designed to fortify oversight and secure treatments for seriously ill patients. Delhi’s health machinery is ramping up surveillance to foster a trustworthy drug ecosystem.
As public health remains paramount, these drives signal a sustained campaign against malpractices, reassuring citizens that their well-being is prioritized amid rising concerns over medicine authenticity.